Yunchao Huang

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Shengxiang Ren, Jianhua Chen, Xingxiang Xu et al. · Journal of Thoracic Oncology · 2021 · 293 citations

Camrelizumab Plus Carboplatin, Medicine, Advanced Squamous Nsclc +8

Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey

Jufang Shi, Le Wang, Jian‐Chao Ran et al. · Cancer · 2021 · 103 citations · Full text

[China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)].

Yaguang Fan, You‐Lin Qiao, Guiqi Wang et al. · PubMed · 2018 · 87 citations · Full text

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis

Shi-ang Qi, Qian Wu, Zhenpu Chen et al. · Scientific Reports · 2021 · 80 citations · Full text

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 65 citations · Full text

Advanced Nonsquamous Nsclc, Oncology, Camrelizumab Plus Carboplatin +9